mRNA Vaccines Beyond COVID-19 What’s Next for Infectious Diseases Abstract Messenger RNA vaccine technology came to global prominence during the COVID 19 pandemic, when rapid design, large scale manufacturing, and emergency authorization demonstrated the practical viability of this platform. Unlike traditional vaccines that rely on attenuated pathogens,
Tag: vaccines
